Press Release: UPDATE OF THE TRANSACTION ANNOUNCED ON NOVEMBER 25, 2025, FOR THE ACQUISITION OF THE MINORITY INTEREST IN THE SUBSIDIARY GROUPE TECHNOLOGIQUE KDA INC.

Dow Jones
2025/12/25

THETFORD MINES, QC, Dec. 24, 2025 /CNW/ - KDA Group Inc. (TSXV: KDA) ("KDA" or the "Corporation"), a leader in innovative technological solutions for healthcare professionals, announced on November 25, 2025, that it had entered into a share transfer agreement to acquire a twenty percent (20%) interest in the issued and outstanding shares of its subsidiary Groupe Technologique KDA inc. ("GTK") currently held by ERxpert Inc. (the "Transaction").

Under the terms of this agreement, ERxpert has agreed to transfer its shares in the GTK subsidiary to KDA in exchange for thirty-five million (35,000,000) common shares of KDA's share capital.

KDA announces that it has received conditional approval from the TSX Venture Exchange for the Transaction on December 18, 2025.

Final approval by the TSX Venture Exchange is conditional upon the filing of certain documents and information requested by the TSX Venture Exchange on or before January 20, 2026, and final acceptance by the TSX Venture Exchange will be issued after satisfactory review of the required documents and information.

ABOUT KDA GROUP

KDA Group is a leader in technological innovations and specialized software solutions (SaaS -- Software as a Service) for the healthcare professionals' market. KDA is a corporation that offers high-quality products and has recognized and respected expertise among the various stakeholders in the pharmaceutical and medical sectors. The technology products developed by KDA aim, among other things, to accelerate the healthcare's digital transformation, and are available for the Canadian and international markets. Additional information about the Corporation is available at www.groupkda.com and on SEDAR+ at www.sedarplus.ca.

CAUTION REGARDING FORWARD-LOOKING STATEMENTS

This press release from KDA Group contains forward-looking statements. Forward-looking statements are typically identified by the words assumption, goal, guidance, objective, outlook, strategy, target, and other similar expressions, or future or conditional verbs such as aim, anticipate, believe, predict, could, expect, intend, may, plan, seek, should, strive, and will. By their nature, forward-looking statements require us to make estimates and assumptions and express opinions based on current conditions and anticipated developments, as well as other factors that Management may deem appropriate under the circumstances. There is inherent uncertainty and significant risk in these estimates, assumptions, and opinions, particularly of a commercial, economic, and competitive nature, and they are therefore subject to change. KDA Group cannot guarantee that these estimates, assumptions, and opinions will prove to be accurate.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.

SOURCE KDA Group Inc.

/CONTACT:

Copyright CNW Group 2025 
 

(END) Dow Jones Newswires

December 24, 2025 11:00 ET (16:00 GMT)

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10